QuidelOrtho (QDEL) Profit After Tax Growth (1y) (2022 - 2026)
QuidelOrtho (QDEL) Profit After Tax Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -12.28% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 99.26% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 4.70% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -27.13% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 125.69% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 89.28% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 51.30% |
| 10 | QuidelOrtho | 967.08 Mn | 826.68 Mn | - | -622.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -622.83% |
| Dec 28, 2025 | 26.74% |
| Sep 28, 2025 | -3,583.42% |
| Jun 29, 2025 | -72.92% |
| Mar 30, 2025 | 99.26% |
| Dec 29, 2024 | 66.24% |
| Sep 29, 2024 | -56.69% |
| Jun 30, 2024 | -177.63% |
| Mar 31, 2024 | -3,595.90% |
| Dec 31, 2023 | -518.78% |
| Oct 1, 2023 | -166.15% |
| Jul 2, 2023 | -183.65% |
| Apr 2, 2023 | -89.83% |
| Oct 2, 2022 | -91.10% |
| Jul 3, 2022 | 232.98% |